Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

L. Paz-Ares, F. Barlesi, S. Siena, M. J. Ahn, A. Drilon, A. Conley, C. Rolfo, J. Wolf, T. Seto, R. Doebele, A. Kapre, D. Chen, S. McCallum, S. Osborne, G. Demetri

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences